Back to School: How biopharma can reboot drug development. Access exclusive analysis here

DB289: Began Phase I testing

Immtech International Inc. (IMMT), Vernon Hills, Ill.
Product: DB289

Read the full 92 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE